Why now? Polls point out that seventy four% of american citizens can not pay for their medications, and Trump faces strain to cut back inflation and health treatment costs. The drug Market is characterised by counterproductive incentives, inefficiencies and anti-competitive tactics that obstruct healthy price cutting war.It is vital to notice th